Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 3
1991 5
1992 6
1993 6
1994 14
1995 8
1996 28
1997 17
1998 17
1999 14
2000 11
2001 15
2002 11
2003 15
2004 8
2005 9
2006 15
2007 11
2008 7
2009 8
2010 15
2011 12
2012 10
2013 17
2014 22
2015 15
2016 15
2017 18
2018 14
2019 17
2020 27
2021 30
2022 16
Text availability
Article attribute
Article type
Publication date

Search Results

417 results
Results by year
Filters applied: . Clear all
Page 1
Field cancerization: Treatment.
Cornejo CM, Jambusaria-Pahlajani A, Willenbrink TJ, Schmults CD, Arron ST, Ruiz ES. Cornejo CM, et al. J Am Acad Dermatol. 2020 Sep;83(3):719-730. doi: 10.1016/j.jaad.2020.03.127. Epub 2020 May 6. J Am Acad Dermatol. 2020. PMID: 32387663 Review.
Other considerations include treatment efficacy, cost, side effects, and patient preference. Field therapies are preferred because they address clinically visible disease and subclinical atypia. ...
Other considerations include treatment efficacy, cost, side effects, and patient preference. Field therapies are preferred because th …
Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial).
Lebwohl M, Kircik L, Lacour JP, Liljedahl M, Lynde C, Mørch MH, Papp KA, Perrot JL, Gold LS, Takhar A, Thaçi D, Warren RB, Wollenberg A. Lebwohl M, et al. J Am Acad Dermatol. 2021 May;84(5):1269-1277. doi: 10.1016/j.jaad.2020.09.037. Epub 2020 Sep 18. J Am Acad Dermatol. 2021. PMID: 32950546 Free article. Clinical Trial.
OBJECTIVE: Assess long-term efficacy and safety of proactive psoriasis management with twice-weekly calcipotriene 0.005%/betamethasone dipropionate 0.064% (Cal/BD) foam. ...
OBJECTIVE: Assess long-term efficacy and safety of proactive psoriasis management with twice-weekly calcipotriene 0.005%/betamethason …
Managing Scalp Psoriasis: An Evidence-Based Review.
Wang TS, Tsai TF. Wang TS, et al. Am J Clin Dermatol. 2017 Feb;18(1):17-43. doi: 10.1007/s40257-016-0222-4. Am J Clin Dermatol. 2017. PMID: 27650520 Review.
RESULTS: To our knowledge, few randomized controlled trials (RCTs) are conducted specifically in scalp psoriasis. Topical corticosteroids provide good effects and are usually recommended as first-line treatment. Calcipotriol-betamethasone dipropionate is well tolera …
RESULTS: To our knowledge, few randomized controlled trials (RCTs) are conducted specifically in scalp psoriasis. Topical corticosteroids pr …
Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events.
Subedi S, Gong Y, Chen Y, Shi Y. Subedi S, et al. Drug Des Devel Ther. 2019 Jul 23;13:2491-2502. doi: 10.2147/DDDT.S200147. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31413544 Free PMC article. Review.
Infliximab, a murine-human monoclonal antibody, is highly efficacious in the treatment of moderate-to-severe psoriasis, with better skin clearance and faster onset of action than topical medications such as methotrexate, narrow-band ultraviolet B, and calcipotriol. Lack of …
Infliximab, a murine-human monoclonal antibody, is highly efficacious in the treatment of moderate-to-severe psoriasis, with better skin cle …
Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
McCormack PL. McCormack PL. Am J Clin Dermatol. 2011 Dec 1;12(6):421-4. doi: 10.2165/11207670-000000000-00000. Am J Clin Dermatol. 2011. PMID: 21967117 Review.
Calcipotriene/betamethasone dipropionate was generally well tolerated, with most adverse drug reactions being lesional or perilesional effects of mild or moderate severity. Calcipotriene/betamethasone dipropionate was often associated with fewer lesion
Calcipotriene/betamethasone dipropionate was generally well tolerated, with most adverse drug reactions being lesional or peri
Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration.
Rademaker M, Agnew K, Andrews M, Armour K, Baker C, Foley P, Frew J, Gebauer K, Gupta M, Kennedy D, Marshman G, Sullivan J. Rademaker M, et al. Australas J Dermatol. 2018 May;59(2):86-100. doi: 10.1111/ajd.12641. Epub 2017 May 23. Australas J Dermatol. 2018. PMID: 28543445 Review.
The topical and systemic therapies commonly used in psoriasis are each discussed separately, with regards to pregnancy exposure, breast-feeding and effects on male fertility and mutagenicity. The systemic therapies included are acitretin, adalimumab, apremilast, certolizum …
The topical and systemic therapies commonly used in psoriasis are each discussed separately, with regards to pregnancy exposure, breast-feed …
Safety of calcipotriene and betamethasone dipropionate foam for the treatment of psoriasis.
Amat-Samaranch V, Puig L. Amat-Samaranch V, et al. Expert Opin Drug Saf. 2020 Apr;19(4):423-432. doi: 10.1080/14740338.2020.1749594. Epub 2020 Apr 13. Expert Opin Drug Saf. 2020. PMID: 32243212 Review.
Most patients have mild disease that is usually controlled with topical treatment. Calcipotriene 0.05% and betamethasone dipropionate 0.064% (Cal/BD) in aerosol foam (Enstilar) is a novel formulation, which has shown promising results in terms of efficacy and safety.Areas …
Most patients have mild disease that is usually controlled with topical treatment. Calcipotriene 0.05% and betamethasone dipropionate …
Drugs for psoriasis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Jun 17;61(1574):89-96. Med Lett Drugs Ther. 2019. PMID: 31381544 Review. No abstract available.
Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis.
Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P. Li M, et al. Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11736-41. doi: 10.1073/pnas.0604575103. Epub 2006 Jul 31. Proc Natl Acad Sci U S A. 2006. PMID: 16880407 Free PMC article.
We show here that topical application of the physiologically active ligand [1alpha,25-(OH)(2)D(3); calcitriol] of the vitamin D receptor, or of its low-calcemic analog MC903 (calcipotriol; Dovonex), induces TSLP expression in epidermal keratinocytes, which results in an at …
We show here that topical application of the physiologically active ligand [1alpha,25-(OH)(2)D(3); calcitriol] of the vitamin D receptor, or …
Erosive pustular dermatosis of the scalp: causes and treatments.
Karanfilian KM, Wassef C. Karanfilian KM, et al. Int J Dermatol. 2021 Jan;60(1):25-32. doi: 10.1111/ijd.14955. Epub 2020 Jun 9. Int J Dermatol. 2021. PMID: 32516510 Review.
Besides corticosteroids, topical tacrolimus and photodynamic therapy were the most commonly used treatments for EPDS. They were effective with few recurrences and adverse effects. Other successful treatment options were topical dapsone, silicone gels, calcipotrio
Besides corticosteroids, topical tacrolimus and photodynamic therapy were the most commonly used treatments for EPDS. They were effective wi …
417 results